News

Transthyretin amyloid cardiomyopathy (ATTR-CM) has been traditionally considered a rare and inexorably fatal condition. However, the development of therapies able…

TULSA, Okla. -Cardiac amyloidosis, once widely considered a fatal diagnosis, is now being detected earlier and treated with newly approved medications that doctors…

On 21 February, Lachlan Guyot and Henry Mayjor will be taking on the iconic Rottnest Channel Swim, swimming from Cottesloe to Rottnest Island as a duo team.This…

Driven by accelerating diagnosis of ATTR cardiomyopathy, sustained reliance on cost-effective chemotherapy, and rapid uptake of disease-modifying therapies in North…

Hear from a current student in the Clinical & Translational Research Certificate Program as they reflect on their experience in the program and the impact it…

The Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL) can effectively capture the multidimensional effect of ATTR, according to a new study…

Amyloid plaques accumulate years before dementia, driven by release of the Aβ peptide from amyloid precursor protein (APP) in neurons. Now, new evidence points to…

ORLANDO, Fla. - Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and nervous system.…

AbstractBackground and Objectives: Hereditary transthyretin amyloidosis (ATTRv) is a rare disease caused by pathogenic variants in the transthyretin (TTR) gene.…

Insulin-derived amyloidosis is a rare form of localised amyloidosis resulting from the aggregation of exogenous insulin into subcutaneous amyloid fibrils at…